BRAFTOVI
Drug timelines are a Plus or Pro feature.
30 regulatory and trial events tracked for BRAFTOVI, covering 2018-06-27 to 2026-07-22. Get the full timeline:
Most recent: EMA Authorised: Braftovi (Encorafenib) — Pierre Fabre Medicament
30 regulatory and trial events tracked for BRAFTOVI, covering 2018-06-27 to 2026-07-22. Get the full timeline:
Most recent: EMA Authorised: Braftovi (Encorafenib) — Pierre Fabre Medicament